The Filing Desk

Anika Therapeutics vs OraSure Technologies

Anika Therapeutics ANIK · OraSure Technologies OSUR · Health Care Equipment

OraSure Technologies reported revenue of $115 million in fiscal 2025, about the same as Anika Therapeutics' $113 million in fiscal 2025. Anika Therapeutics' revenue fell 5.9% in its latest year, and OraSure Technologies' fell 38.1%. Anika Therapeutics had an operating margin of -9.8%, against -62.6% at OraSure Technologies. Free cash flow was $4 million at Anika Therapeutics and −$53 million at OraSure Technologies.

Side by side

Anika TherapeuticsOraSure Technologies
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$113M$115M
Revenue growth−5.9%−38.1%
Revenue growth a year, last 5 years−2.9%−7.7%
Gross margin56.6%41.9%
Operating margin−9.8%−62.6%
Net margin−9.6%−59.8%
Free cash flow$4M−$53M
Free cash flow margin3.9%−46.3%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$10M$15M
Change in diluted share count−2.6%−1.3%
Last close$13.28$3.61
P/E at the last close——
Insider trades, last 12 monthsbought $264,308, sold $0bought $456,495, sold $0
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Anika TherapeuticsOraSure Technologies
Operating margin
Percent of revenue
Anika TherapeuticsOraSure Technologies
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Anika TherapeuticsOraSure Technologies

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Anika Therapeutics and OraSure Technologies pages.